LEIDEN, the Netherlands, May 23, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced the appointment of Dr.
… transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the … is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called …
… into other forms of genetic blindness Validate and expand Axiomer ® : Further validate and expand ProQR's proprietary Axiomer ® RNA editing platform through first development … QR-1123, QR-421a, QR-411a, QR-504, the potential of our Axiomer ® editing platform, our plans and timing of …
… into clinical development and further advance our novel Axiomer ® RNA editing platform. With these events we look … or halt corneal degeneration in patients with FECD3. About Axiomer ProQR is pioneering a next-generation RNA technology called Axiomer ® , which could potentially yield a new class of …
… and key opinion leaders and introduced next-generation Axiomer ® RNA technology platform. LEIDEN, the Netherlands, … trial in 2018. Beyond that, we are excited about the Axiomer ® platform technology we announced at our R&D day. … the event, the Company also introduced its next-generation Axiomer ® RNA technology platform, which has the potential to …
… to ProQR’s novel RNA editing platform technology called Axiomer LEIDEN, the Netherlands, May 09, 2017 (GLOBE … led to a novel proprietary RNA editing platform, called Axiomer, which in our view is the next step in RNA …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today announced … is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called …
… supports ProQR’s strategic focus on its proprietary Axiomer ® RNA editing technology platform and continued … of ProQR. “We look forward to continuing to advance our Axiomer RNA editing platform, with an initial focus on … is pioneering a next-generation RNA technology called Axiomer ® , which uses a cell’s own editing machinery called …
… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform, today announced … is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called …